Amneal Pharmaceuticals, Inc. (AMRX) vs Iovance Biotherapeutics, Inc. (IOVA)
A side-by-side comparison of Amneal Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AMRX
Amneal Pharmaceuticals, Inc.
$20.26HealthcareDelayed quote: Oct 6, 2026, 10:15 AM EDT
IOVA
Iovance Biotherapeutics, Inc.
$13.20HealthcareDelayed quote: Oct 6, 2026, 10:15 AM EDT
Total return — AMRX vs IOVA
growth of $100 · dividends reinvested · last 10yAMRX -13.6% (-1.5%/yr)IOVA +87.7% (+6.5%/yr)IOVA compounded faster over this window
AMRX IOVA
AMRX vs IOVA: by the numbers
- •AMRX is the larger company ($6.47B vs $5.89B market cap).
- •AMRX is profitable (5.05% net margin) while IOVA runs a net loss (-89.09%).
Metrics side by side
Valuation
| Metric | AMRX | IOVA |
|---|---|---|
| P/E ratio | 41.56 | N/A |
| Forward P/E | 19.79 | N/A |
| P/S ratio | 2.08 | 18.14 |
| P/B ratio | 195.90 | 8.01 |
| EV / EBITDA | 15.29 | N/A |
| FCF yield | 1.28% | N/A |
Profitability
| Metric | AMRX | IOVA |
|---|---|---|
| Gross margin | 39.32% | 97.23% |
| Operating margin | 12.93% | -153.08% |
| Net margin | 5.05% | -89.09% |
| ROE | 476.51% | -39.33% |
| ROIC | 13.45% | -37.26% |
Growth (annualized)
| Metric | AMRX | IOVA |
|---|---|---|
| Revenue CAGR (5Y) | 8.67% | N/A |
| EPS CAGR (5Y) | -17.72% | N/A |
| FCF CAGR (5Y) | -14.46% | N/A |
| Total return CAGR (5Y) | 30.25% | -11.55% |
Frequently asked
- Is AMRX or IOVA more profitable?
- AMRX runs the higher net margin — AMRX at 5.05% versus IOVA at -89.09%.
- How have AMRX and IOVA total returns compared?
- Over the past 10 years, AMRX delivered -1.73% and IOVA delivered 5.84% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Amneal Pharmaceuticals P/E ratioAmneal Pharmaceuticals ROEIovance Biotherapeutics ROEAmneal Pharmaceuticals operating marginIovance Biotherapeutics operating marginAmneal Pharmaceuticals revenue growthIovance Biotherapeutics revenue growthAmneal Pharmaceuticals free cash flowIovance Biotherapeutics free cash flow
Amneal Pharmaceuticals & Iovance Biotherapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.